Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oncology Pharma Inc (OP: ONPH ) 0.0002 +0.0001 (+100.00%) Streaming Delayed Price Updated: 9:30 AM EST, Jan 7, 2025 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Oncology Pharma Inc Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System July 12, 2022 SAN FRANCISCO, CA / ACCESSWIRE / July 12, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is furthering progress in discussions with investors and developing the... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System June 29, 2022 SAN FRANCISCO, CA / ACCESSWIRE / June 29, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to be reviewing the financing for taking the steps on moving... From Oncology Pharma Inc. Via AccessWire Exposures Product Safety Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development June 08, 2022 SAN FRANCISCO, CA / ACCESSWIRE / June 8, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased that the initial feasibility stage is complete and results have... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development May 09, 2022 SAN FRANCISCO, CA / ACCESSWIRE / May 9, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to execute its next phase with Connect2Trials, Inc. Originally,... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer April 13, 2022 SAN FRANCISCO, CA / ACCESSWIRE / April 13, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma ("The Company") is pleased to announce that it has completed the initial feasibility phase of its... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Reports on Progress with Ribera Solutions March 02, 2022 SAN FRANCISCO, CA / ACCESSWIRE / March 2, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to announce progress with its investment with Ribera Solutions'... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Releases Further Feasibility Studies, Data and Capacities February 23, 2022 SAN FRANCISCO, CA / ACCESSWIRE / February 23, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") looks toward releasing further results of the studies under the... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Expands on Feasibility Studies and Data February 17, 2022 SAN FRANCISCO, CA / ACCESSWIRE / February 17, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") wants to expand on a previously announced press release that included... From Oncology Pharma Inc. Via AccessWire Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine February 14, 2022 SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen BioPharma, Inc. (OTC PINK:RGBP) and (OTC PINK:RGBPP): announced that they intend to... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Gives Update on Technology, Formulation and Data Creation February 08, 2022 SAN FRANCISCO, CA / ACCESSWIRE / February 8, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to announce that the co-development agreement and ongoing... From Oncology Pharma Inc. Via AccessWire Oncology Pharma's New Year Update January 10, 2022 SAN FRANCISCO, CA / ACCESSWIRE / January 10, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") update on its progress to kick off the new year. The Company has... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Meeting Towards Future Developments December 17, 2021 SAN FRANCISCO, CA / ACCESSWIRE / December 17, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. ("The Company") conducted a meeting with the Board of Directors, executives, and... From Oncology Pharma Inc. Via AccessWire Oncology Pharma Year End Review and Outlook December 09, 2021 SAN FRANCISCO, CA / ACCESSWIRE / December 9, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") and its Chief Executive are pleased to give a year end update and... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Oncology Pharma Research and Vision November 30, 2021 SAN FRANCISCO, CA / ACCESSWIRE / November 30, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is a pioneering oncology company dedicated to providing the financing... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Oncology Pharma Reveals Plans for Development of Lead Cancer Drug Candidate November 08, 2021 SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2021 / Oncology Pharma, Inc. (the "Company") is pleased to provide some insight into the progress of its co-development project with NanoSmart... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress October 27, 2021 SAN FRANCISCO, CA / ACCESSWIRE / October 27, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Pursuant to previous communications, Oncology Pharma, Inc. (the "Company") is making progress towards pursuing... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior Listing October 15, 2021 SAN FRANCISCO, CA / ACCESSWIRE / October 15, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Pursuant to previously announced press release, Oncology Pharma, Inc. (the "Company") has retained the services... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures Intellectual Property Legal Regulatory Oncology Pharma, Inc. Update on PCAOB Audit Selection Process and License Agreement October 12, 2021 SAN FRANCISCO, CA / ACCESSWIRE / October 12, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") would like to update investors on its progress. The Company is in the... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug Product September 13, 2021 SAN FRANCISCO, CA / ACCESSWIRE / September 13, 2021 / Oncology Pharma, Inc. (OTC PINK:ONPH). In keeping with management's commitment to continue implementation of Oncology Pharma's ("the Company")... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Oncology Pharma's Co-Development Agreement Pursues Strategic and Direct Objectives August 23, 2021 SAN FRANCISCO, CA / ACCESSWIRE / August 23, 2021 / Oncology Pharma, Inc. (OTC PINK:ONPH) defines its objective and strategy for recently signed Co-Development deal. The primary goal of the... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc. August 19, 2021 SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) With much anticipation, Oncology Pharma, Inc. has finalized a Co-Development Agreement with NanoSmart... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Oncology Pharma, Inc. To Move to Conducting Trials on Licensed IP July 20, 2021 SAN FRANCISCO, CA / ACCESSWIRE / July 20, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is laying out and taking necessary steps to move its licensed IP forward.... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase June 30, 2021 SAN FRANCISCO, CA / ACCESSWIRE / June 30, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is developing a program to establish the use of its license utilizing NR2F6... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Oncology Pharma, Inc. Eyes Collaboration with Patent Opportunities Amongst Its Licensed Intellectual Properties June 15, 2021 SAN FRANCOSCO, CA / ACCESSWIRE / June 15, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the 'Company') has been continuing its research and work reviewing and implementing... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma and Ribera Solutions Release White Paper Regarding Patient Engagement and Retention Platform June 09, 2021 SAN FRANCISCO, CA / ACCESSWIRE / June 9, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the 'Company') is releasing a White Paper outlining 5 innovative ways to improve patient... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer May 18, 2021 SAN FRANCISCO, CA / ACCESSWIRE / May 18, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is pursuing, through its licensing arrangements, the development of a small... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma, Inc. Has Submitted Its Initial Application to List the Company on the Capital Markets Tier of the NASDAQ Exchange May 12, 2021 SAN FRANCISCO, CA / ACCESSWIRE / May 12, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") has submitted its initial application to the NASDAQ to begin the process of... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma Enters into License Agreement for Small Molecules Intellectual Property for the Treatment of Colon Cancer May 07, 2021 SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) ONPH has entered into a licensing agreement with Regen BioPharma, Inc. for a technology utilizing small molecules to... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma, Inc. Prepares Plan Toward Funding Development and Implementation of Ribera Solutions' Patient Engagement and Retention Platform April 21, 2021 SAN FRANCISCO, CA / ACCESSWIRE / April 21, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is moving ahead with advancing its efforts with Ribera Solutions' Conect2Med... From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Oncology Pharma, Inc. Addresses Pancreatic Cancer, the Need for an Effective Therapy and the Potential of mRNA Technology April 14, 2021 SAN FRANCISCO, CA / ACCESSWIRE / April 14, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) On April 7, 2021 Oncology Pharma, Inc. (the "Company") reported that it had been granted an exclusive worldwide... From Oncology Pharma Inc. Via AccessWire Topics Death Intellectual Property Exposures Death Intellectual Property Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
